TickerFactsScreenerDevelopers

Galmed Pharmaceuticals Ltd. (GLMD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $146.0K2012: $718.0K2013: $137.0K2014: $23.74M2015: $4.16M2016: $3.10M2017: $13.02M2018: $24.16M2019: $15.93M2020: $6.95M2021: $2.88M2022: $2.02M2023: $2.86M2024: $4.65M2025: $3.98M$3.98M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.98M-14.3%
2024$4.65M+62.6%
2023$2.86M+41.9%
2022$2.02M-30.1%
2021$2.88M-58.5%
2020$6.95M-56.4%
2019$15.93M-34.1%
2018$24.16M+85.5%
2017$13.02M+320.4%
2016$3.10M-25.5%
2015$4.16M-82.5%
2014$23.74M+17225.5%
2013$137.0K-80.9%
2012$718.0K+391.8%
2011$146.0K—